Microbiology · Study notes
Fungi
On this page 7 sections
In 30 seconds
Fungi are eukaryotic microbes including yeasts and molds. This section covers their basic biology, how they cause disease (mycoses), and why antifungal treatment is challenging.
Why this matters
Fungal infections range from common (yeast infections, athlete's foot) to serious (systemic infections in immunocompromised patients). Because fungi are eukaryotes like us, treating them safely is harder — an important clinical point.
The college version
Core Explanation
What fungi are. Fungi are eukaryotes (true nucleus, like human cells) with a cell wall made of chitin (not peptidoglycan). They are heterotrophs that absorb nutrients from their environment, and many are decomposers. Two basic forms:
- Yeasts: single-celled fungi that typically reproduce by budding (e.g., Candida).
- Molds: multicellular fungi that grow as branching filaments (hyphae) forming visible fuzzy colonies (like bread mold). Some fungi can switch between yeast and mold forms.
Fungi are also enormously beneficial — decomposing organic matter, making foods (bread, cheese), and producing medicines (penicillin comes from a mold).
How fungi cause disease. Fungal infections are called mycoses. They range by location and severity:
- Superficial/cutaneous: on skin, hair, nails — like athlete's foot and ringworm (dermatophyte infections).
- Mucosal: like oral thrush or vaginal yeast infections (often Candida).
- Systemic (deep): infections of internal organs, which can be serious, especially in immunocompromised people (e.g., those with HIV/AIDS, on chemotherapy, or on immunosuppressants).
Many fungal infections are opportunistic — they take hold when defenses are weakened or normal microbiota are disrupted (recall antibiotics disrupting flora can trigger yeast overgrowth).
Why antifungals are challenging. Because fungi are eukaryotes like human cells, they share more cellular machinery with us than bacteria do. This makes selective toxicity harder — it's difficult to attack the fungus without also affecting human cells, so antifungal drugs can have more side effects and are fewer in number. Antifungals often target fungal-specific features, such as the chitin cell wall or components of the fungal cell membrane (like ergosterol) that differ from human membranes.
Common infections. Frequently encountered fungal infections include *Candida* infections (thrush, yeast infections, and serious bloodstream infections in vulnerable patients), dermatophytes (athlete's foot, ringworm), and various molds causing respiratory or systemic disease. Recognizing that fungal infections often affect immunocompromised patients is a key clinical theme.
How It Works
Fungi and their treatment:
Fungi = eukaryotes, chitin cell wall, heterotrophs; forms: yeasts (single-celled) + molds (hyphae)
Disease (mycoses): superficial (athlete's foot) | mucosal (thrush, yeast infection) | systemic (serious, immunocompromised)
Often opportunistic (weak defenses / disrupted microbiota)
Antifungals harder (eukaryotic like us) → target fungal cell wall (chitin) or membrane (ergosterol); more side effectsImportant Relationships and Comparisons
| Form | Description | Example |
|---|---|---|
| Yeast | Single-celled, budding | Candida |
| Mold | Multicellular hyphae | Bread mold |
| Mycosis type | Location | Example |
|---|---|---|
| Superficial/cutaneous | Skin, hair, nails | Athlete's foot, ringworm |
| Mucosal | Mouth, vaginal | Thrush, yeast infection |
| Systemic | Internal organs | Serious (immunocompromised) |
High-Yield Pre-Nursing Connections
Opportunistic fungal infections are a major concern in immunocompromised patients (HIV/AIDS, chemotherapy, transplant, prolonged antibiotics) — recognizing this risk guides prevention and care. Common issues include oral thrush, vaginal yeast infections (sometimes after antibiotics disrupt normal flora), and athlete's foot. Because antifungals can be more toxic (fungi are eukaryotes), monitoring for side effects matters. Understanding fungi supports care in wound, skin, and systemic infection management.
Common Confusions
- Fungi are eukaryotes (chitin wall) — harder to treat than bacteria.
- Yeasts (single-celled) vs molds (filamentous hyphae).
- Many fungal infections are opportunistic — worse with weakened immunity or disrupted flora.
- Antifungals target fungal-specific features (chitin, ergosterol) but can still affect human cells more than antibiotics do.
Memory Aids
- "Fungi = eukaryotes with chitin walls (harder to treat)."
- "Yeast = single cell; Mold = fuzzy filaments."
- "Opportunistic = strikes when defenses are down."
Quick Recap
- Fungi are eukaryotes (chitin cell wall) in two forms: yeasts (single-celled) and molds (filamentous hyphae).
- Fungal infections (mycoses) range from superficial (athlete's foot, ringworm) to mucosal (thrush, yeast infections) to systemic (serious, especially in the immunocompromised); many are opportunistic.
- Antifungals are harder to make selectively toxic (fungi are eukaryotes like us) — they target fungal-specific features (chitin wall, ergosterol membrane) and can have more side effects.
- Immunocompromised patients are especially vulnerable to fungal infections.
Key terms
Key terms are emphasized and defined within the main notes.
Important formulas or processes
See the formulas, procedures, and process blocks in the main notes where applicable.
Common mistakes
See the labeled common-mistake callouts in the main notes where present.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Simple idea
Fungi are germs like yeasts and molds. They're built more like our own cells, which makes them harder to treat safely — and they often cause trouble when a person's defenses are weak.
Analogy
Think of fungi as a different kind of "plant-like" germ — including yeasts (tiny single blobs, like the yeast that makes bread rise) and molds (fuzzy, spreading threads, like the mold on old bread). Here's the tricky part: unlike bacteria, fungi are built a lot like our own cells (both have a nucleus and similar insides). So attacking a fungus without also harming you is like trying to remove one specific weed from a flowerbed without damaging the flowers — much harder than spraying bacteria, which are totally different from us. That's why antifungal medicines can have more side effects. Fungi also tend to strike when your defenses are down — like yeast infections or thrush appearing after antibiotics wipe out your helpful bacteria, or serious fungal infections in people with weakened immune systems.
What is actually happening
This "they're like us" problem is a real clinical challenge: fungal infections can be dangerous, especially in immunocompromised patients (people with HIV/AIDS, on chemotherapy, or transplant medicines), and their treatments must be watched carefully for side effects. Common everyday fungal issues include athlete's foot, ringworm, thrush, and yeast infections — the last often popping up after antibiotics disturb the normal balance of good microbes. Recognizing who's at risk helps prevent and catch these infections early.
Where the analogy stops
Weeds are just nuisances, but some fungal infections can spread deep into the body and become life-threatening in vulnerable patients — so they're taken very seriously, not treated as minor.
Key takeaway
Use the quick-review or recap section in the main notes.
Study tools & related lessonsYou’ll learn to · Related
You’ll learn to
- Review and explain the concepts presented in this lesson.
- Describe the basic biology of fungi (yeasts vs molds).
- Explain how fungi cause disease (mycoses).
- Explain why antifungal drugs are challenging.
- Identify common fungal infections.
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.